Items where authors include "Lutz, C."

Article

Schytte, T., Kristiansen, C., Khalil, A. et al. (17 more authors) (2024) Overall survival following heterogeneous FDG-guided dose-escalation for locally advanced NSCLC in the international phase III NARLAL2 trial. Journal of Clinical Oncology, 42 (17_suppl). ISSN 0732-183X

Motzer, R.J., Porta, C., Eto, M. et al. (238 more authors) (2024) Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of Clinical Oncology, 42 (11). pp. 1222-1228. ISSN 0732-183X